Early cancer drug trial halted after testing in 40 patients
Disease control
Terminated
This was an early safety study testing a new drug called LB4330 in patients with advanced solid tumors that had stopped responding to standard treatments. The trial aimed to find the safest dose and see how the drug behaves in the body. It was terminated early and enrolled 40 par…
Phase: PHASE1 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC